Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
35.99
-0.16 (-0.44%)
Feb 21, 2025, 4:00 PM EST - Market closed

Bright Minds Biosciences Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Bright Minds Biosciences stock have an average target of 84.33, with a low estimate of 75 and a high estimate of 93. The average target predicts an increase of 134.32% from the current stock price of 35.99.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $75 $84.33 $85 $93
Change +108.39% +134.32% +136.18% +158.41%

Analyst Ratings

The average analyst rating for Bright Minds Biosciences stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25
Strong Buy 011
Buy 133
Hold 000
Sell 000
Strong Sell 000
Total 144

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$85
Strong Buy Reiterates $85 +136.18% Feb 19, 2025
Piper Sandler
Piper Sandler
Buy
Initiates
$93
Buy Initiates $93 +158.41% Jan 23, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
n/a
Buy Initiates n/a n/a Jan 10, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$85
Strong Buy Initiates $85 +136.18% Jan 10, 2025
Baird
Baird
Buy
Initiates
$75
Buy Initiates $75 +108.39% Nov 25, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.